Kim Y - Search Results

1

Control of T(H)17/T(reg) balance by hypoxia-inducible factor 1.

Dang EV, Barbi J, Yang HY, Jinasena D, Yu H, Zheng Y, Bordman Z, Fu J, Kim Y, Yen HR, Luo W, Zeller K, Shimoda L, Topalian SL, Semenza GL, Dang CV, Pardoll DM, Pan F. Dang EV, et al. Among authors: kim y. Cell. 2011 Sep 2;146(5):772-84. doi: 10.1016/j.cell.2011.07.033. Epub 2011 Aug 25. Cell. 2011. PMID: 21871655 Free PMC article.

2

Autologously Humanized Mice for Immune-Oncologic Studies.

Fu J, Kim YJ. Fu J, et al. Curr Protoc Pharmacol. 2020 Jun;89(1):e76. doi: 10.1002/cpph.76. Curr Protoc Pharmacol. 2020. PMID: 32469451 Free PMC article.

3

Intratumoral administration of TLR4 agonist absorbed into a cellular vector improves antitumor responses.

Davis MB, Vasquez-Dunddel D, Fu J, Albesiano E, Pardoll D, Kim YJ. Davis MB, et al. Clin Cancer Res. 2011 Jun 15;17(12):3984-92. doi: 10.1158/1078-0432.CCR-10-3262. Epub 2011 May 4. Clin Cancer Res. 2011. PMID: 21543518 Free PMC article.

4

Immunologic consequences of signal transducers and activators of transcription 3 activation in human squamous cell carcinoma.

Albesiano E, Davis M, See AP, Han JE, Lim M, Pardoll DM, Kim Y. Albesiano E, et al. Among authors: kim y. Cancer Res. 2010 Aug 15;70(16):6467-76. doi: 10.1158/0008-5472.CAN-09-4058. Epub 2010 Aug 3. Cancer Res. 2010. PMID: 20682796 Free PMC article.

5

Preclinical evidence that PD1 blockade cooperates with cancer vaccine TEGVAX to elicit regression of established tumors.

Fu J, Malm IJ, Kadayakkara DK, Levitsky H, Pardoll D, Kim YJ. Fu J, et al. Cancer Res. 2014 Aug 1;74(15):4042-52. doi: 10.1158/0008-5472.CAN-13-2685. Epub 2014 May 8. Cancer Res. 2014. PMID: 24812273 Free PMC article.

6

Biodegradable STING agonist nanoparticles for enhanced cancer immunotherapy.

Wilson DR, Sen R, Sunshine JC, Pardoll DM, Green JJ, Kim YJ. Wilson DR, et al. Nanomedicine. 2018 Feb;14(2):237-246. doi: 10.1016/j.nano.2017.10.013. Epub 2017 Nov 7. Nanomedicine. 2018. PMID: 29127039 Free PMC article.

7

The role of STAT3 activation in modulating the immune microenvironment of GBM.

See AP, Han JE, Phallen J, Binder Z, Gallia G, Pan F, Jinasena D, Jackson C, Belcaid Z, Jeong SJ, Gottschalk C, Zeng J, Ruzevick J, Nicholas S, Kim Y, Albesiano E, Pardoll DM, Lim M. See AP, et al. Among authors: kim y. J Neurooncol. 2012 Dec;110(3):359-68. doi: 10.1007/s11060-012-0981-6. Epub 2012 Oct 25. J Neurooncol. 2012. PMID: 23096132 Free PMC article.

8

STAT3 regulates arginase-I in myeloid-derived suppressor cells from cancer patients.

Vasquez-Dunddel D, Pan F, Zeng Q, Gorbounov M, Albesiano E, Fu J, Blosser RL, Tam AJ, Bruno T, Zhang H, Pardoll D, Kim Y. Vasquez-Dunddel D, et al. Among authors: kim y. J Clin Invest. 2013 Apr;123(4):1580-9. doi: 10.1172/JCI60083. J Clin Invest. 2013. PMID: 23454751 Free PMC article.

9

Caspase-1 from Human Myeloid-Derived Suppressor Cells Can Promote T Cell-Independent Tumor Proliferation.

Zeng Q, Fu J, Korrer M, Gorbounov M, Murray PJ, Pardoll D, Masica DL, Kim YJ. Zeng Q, et al. Cancer Immunol Res. 2018 May;6(5):566-577. doi: 10.1158/2326-6066.CIR-17-0543. Epub 2018 Apr 13. Cancer Immunol Res. 2018. PMID: 29653983 Free PMC article.

10

STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade.

Fu J, Kanne DB, Leong M, Glickman LH, McWhirter SM, Lemmens E, Mechette K, Leong JJ, Lauer P, Liu W, Sivick KE, Zeng Q, Soares KC, Zheng L, Portnoy DA, Woodward JJ, Pardoll DM, Dubensky TW Jr, Kim Y. Fu J, et al. Among authors: kim y. Sci Transl Med. 2015 Apr 15;7(283):283ra52. doi: 10.1126/scitranslmed.aaa4306. Sci Transl Med. 2015. PMID: 25877890 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

82,753 results

Search Page